Embattled cord-blood bank Cordlife’s group director for quality and operations, Tan Huiying, will resign from the company effective Nov 4, four months after she assumed her current position.
In an announcement on Monday (Sep 9), Cordlife said that Tan was leaving to pursue her “personal interests” and that her resignation had been accepted by the company’s board of directors.
In her role, Tan is responsible for the group’s operations, information systems and technology and business development activities. She is also responsible for ensuring that the group’s quality standards in service and product offerings are maintained according to applicable standards.
Her resignation comes about two weeks after the Health Ministry said Cordlife will be allowed to resume cord-blood banking services “in a controlled manner” from Sep 15.
Tan joined the company as a business development and technical executive in June 2006. Prior to her current position, she served as business unit director for the diagnostics team from January 2014 to June 2016. In this position, her role involved developing and implementing growth and product strategies for the group’s diagnostics business to meet financial and non-financial goals.
Shares of Cordlife closed flat at S$0.14 on Monday, before the announcement.
